Ultrasound pain management device makes way for new FDA category

Article

The US Food and Drug Administration created a new category for ZetrOZ's Acoustic Medicine device.

ZetrOZ, a medical technology company that produces wearable ultrasound devices to reduce pain and inflammation, now comes under a new FDA category, created for just these types of therapeuties.

ZetrOZ's sustained acoustic medicine device is an at-home, long-duration ultrasound therapy instrument, where patients, such as teenage and adult athletes recovering from sports injuries get trained on the use of the device, and then can apply it directly at home. The device can treat inflammation, pain, and other unresolved medical issues such as cartilage degeneration, miniscus injuries and ankle sprains. The localized treatment allows healing without a surgical procedure, and is typically applied once a day for 6 to 8 weeks.

The FDA initially cleared ZetrOZ's sustained acoustic medicine device in 2013, with expanded indications in 2020.

This article was originally posted on Contemporary Pediatrics®.

Related Videos
Study unveils maternal mortality tracking trends | Image Credit: obhg.com
How Harmonia Healthcare is revolutionizing hyperemesis gravidarum care | Image Credit: hyperemesis.org
Exploring the intersection of heart health and women's health | Image Credit: cedars-sinai.org
Unlocking the benefits of DHEA | Image Credit: drannacabeca.com
Unlocking the power of oxytocin | Image credit: drannacabeca.com
Shocking maternal health findings from 2023 March of Dimes report card | Image Credit: marchofdimes.org
The importance of maternal vaccination | Image Credit: nfid.org.
The importance of diversity in obstetrics | Image Credit: © stanfordchildrens.org
Related Content
© 2024 MJH Life Sciences

All rights reserved.